The Motley Fool

FTSE 100 shares: here’s where I’d invest £20k now to make a passive income

Image source: Getty Images.

Buying FTSE 100 shares to make a passive income could become an increasingly popular move. After all, the potential to generate an income elsewhere is relatively low. Assets such as bonds and cash have low yields, while buy-to-let property includes diversification challenges.

With sectors such as healthcare, utilities and consumer goods remaining relatively unpopular among investors focused on growth, now could be a good time to capitalise on high yields. Over time, they could provide a worthwhile income from a £20k investment, or any other amount.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

Making a passive income with utility stocks

A number of FTSE 100 shares offer high passive incomes at the present time. However, the uncertain economic outlook means there may be value in purchasing businesses that are relatively unreliant on the economy for their profits. They could deliver resilient incomes for investors that grow in line with inflation.

As such, purchasing stocks such as SSE and National Grid could be a shrewd move. They offer dividend yields that are in excess of 5%. SSE has a dividend plan to raise shareholder payouts by at least as much as inflation over the next few years.

Meanwhile, National Grid has a long track record of dividend growth. The sector could become more popular if the current stock market bubble bursts during the course of 2021.

Buying FTSE 100 shares in the healthcare sector

Healthcare stocks such as GSK and AstraZeneca could also offer worthwhile passive incomes at the present time. GSK has a yield of 5%, and could benefit from its plans to split into two businesses. It may provide greater efficiencies and a sharper focus within pharmaceuticals and consumer healthcare.

AstraZeneca’s yield of around 3% is lower than many FTSE 100 shares. However, its double-digit earnings growth forecasts over the next couple of years suggest that passive income growth could be strong. It may also be able to capitalise on long-term growth trends in emerging markets, where it has invested significant sums of capital over recent years.

Consumer goods companies with high yields

FTSE 100 shares with the largest passive incomes at the present time include consumer goods companies such as Imperial Brands and British American Tobacco. They have dividend yields of just over 8%, which have been aided by disappointing share price performances over recent years.

Although investor sentiment may be weak towards the sector, British American Tobacco and Imperial Brands have strong brands that are likely to experience resolute demand for their products even in the most challenging economic circumstances. This may lead to rising passive incomes over the long run.

The outlook for the economy remains difficult to predict. So their defensive characteristics could be a useful ally. Certainly for an investor who’s seeking to obtain a worthwhile passive income from a £20k investment during what could prove to be a tough year for the world economy.

A Top Share with Enormous Growth Potential

Savvy investors like you won’t want to miss out on this timely opportunity…

Here’s your chance to discover exactly what has got our Motley Fool UK analyst all fired up about this ‘pure-play’ online business (yes, despite the pandemic!).

Not only does this company enjoy a dominant market-leading position…

But its capital-light, highly scalable business model has previously helped it deliver consistently high sales, astounding near-70% margins, and rising shareholder returns … in fact, in 2019 it returned a whopping £150m+ to shareholders in dividends and buybacks!

And here’s the really exciting part…

While COVID-19 may have thrown the company a curveball, management have acted swiftly to ensure this business is as well placed as it can be to ride out the current period of uncertainty… in fact, our analyst believes it should come roaring back to life, just as soon as normal economic activity resumes.

That’s why we think now could be the perfect time for you to start building your own stake in this exceptional business – especially given the shares look to be trading on a fairly undemanding valuation for the year to March 2021.

Click here to claim your copy of this special report now — and we’ll tell you the name of this Top Growth Share… free of charge!

Peter Stephens owns shares of AstraZeneca, British American Tobacco, GlaxoSmithKline, Imperial Brands, and SSE. The Motley Fool UK has recommended GlaxoSmithKline and Imperial Brands. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Where to invest £1,000 right now

Renowned stock-picker Mark Rogers and his select team of expert analysts at The Motley Fool UK have just revealed 6 "Best Buy" shares that they believe UK investors should consider buying NOW.

So if you’re looking for more top stock ideas to try and best position your portfolio in this market, then I have some good news for your today -- because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.